The Zucker Hillside Hospital
13
1
1
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
15.4%
2 terminated/withdrawn out of 13 trials
81.8%
-4.7% vs industry average
31%
4 trials in Phase 3/4
67%
6 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD)
Role: collaborator
Electroconvulsive Therapy Amplitude Titration
Role: collaborator
Cognitive Behavioral Social Skills Training for Youth at Risk of Psychosis
Role: collaborator
From Intention to Action:Scoring Your College Goals
Role: lead
Targeting Cognition in Bipolar Disorder With Pramipexole
Role: collaborator
Adjunctive Treatment for Decreasing Symptoms of Schizophrenia
Role: collaborator
Optimizing Response in Psychosis Study
Role: collaborator
D-serine for the Schizophrenia Prodrome
Role: collaborator
Event Marker Ingested To Trigger Event Recorder 3.0 Psychiatry Study
Role: collaborator
Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics
Role: collaborator
The Role of Antidepressants or Antipsychotics in Preventing Psychosis
Role: collaborator
Treatment for First-Episode Schizophrenia
Role: collaborator
Topiramate for Binge Eating Disorder Among Adolescents
Role: lead
All 13 trials loaded